Literature DB >> 12728155

Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study.

W S Lim1, M M van der Eerden, R Laing, W G Boersma, N Karalus, G I Town, S A Lewis, J T Macfarlane.   

Abstract

BACKGROUND: In the assessment of severity in community acquired pneumonia (CAP), the modified British Thoracic Society (mBTS) rule identifies patients with severe pneumonia but not patients who might be suitable for home management. A multicentre study was conducted to derive and validate a practical severity assessment model for stratifying adults hospitalised with CAP into different management groups.
METHODS: Data from three prospective studies of CAP conducted in the UK, New Zealand, and the Netherlands were combined. A derivation cohort comprising 80% of the data was used to develop the model. Prognostic variables were identified using multiple logistic regression with 30 day mortality as the outcome measure. The final model was tested against the validation cohort.
RESULTS: 1068 patients were studied (mean age 64 years, 51.5% male, 30 day mortality 9%). Age >/=65 years (OR 3.5, 95% CI 1.6 to 8.0) and albumin <30 g/dl (OR 4.7, 95% CI 2.5 to 8.7) were independently associated with mortality over and above the mBTS rule (OR 5.2, 95% CI 2.7 to 10). A six point score, one point for each of Confusion, Urea >7 mmol/l, Respiratory rate >/=30/min, low systolic(<90 mm Hg) or diastolic (</=60 mm Hg) Blood pressure), age >/=65 years (CURB-65 score) based on information available at initial hospital assessment, enabled patients to be stratified according to increasing risk of mortality: score 0, 0.7%; score 1, 3.2%; score 2, 3%; score 3, 17%; score 4, 41.5% and score 5, 57%. The validation cohort confirmed a similar pattern.
CONCLUSIONS: A simple six point score based on confusion, urea, respiratory rate, blood pressure, and age can be used to stratify patients with CAP into different management groups.

Entities:  

Mesh:

Year:  2003        PMID: 12728155      PMCID: PMC1746657          DOI: 10.1136/thorax.58.5.377

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  20 in total

1.  [Optimization of the antibiotics policy in the Netherlands. II. SWAB guidelines for the antimicrobial therapy of pneumonia in patients at home and as nosocomial infections. The Netherlands Antibiotic Policy Foundation].

Authors:  M E van Kasteren; W J Wijnands; E E Stobberingh; R Janknegt; J W van der Meer
Journal:  Ned Tijdschr Geneeskd       Date:  1998-04-25

2.  Community-acquired pneumonia in the elderly: A multivariate analysis of risk and prognostic factors.

Authors:  R Riquelme; A Torres; M El-Ebiary; J P de la Bellacasa; R Estruch; J Mensa; J Fernández-Solá; C Hernández; R Rodriguez-Roisin
Journal:  Am J Respir Crit Care Med       Date:  1996-11       Impact factor: 21.405

3.  Monte Carlo methods in clinical research: applications in multivariable analysis.

Authors:  J Concato; A R Feinstein
Journal:  J Investig Med       Date:  1997-08       Impact factor: 2.895

4.  Do pulmonary radiographic findings at presentation predict mortality in patients with community-acquired pneumonia?

Authors:  P B Hasley; M N Albaum; Y H Li; C R Fuhrman; C A Britton; T J Marrie; D E Singer; C M Coley; W N Kapoor; M J Fine
Journal:  Arch Intern Med       Date:  1996-10-28

5.  A prediction rule to identify low-risk patients with community-acquired pneumonia.

Authors:  M J Fine; T E Auble; D M Yealy; B H Hanusa; L A Weissfeld; D E Singer; C M Coley; T J Marrie; W N Kapoor
Journal:  N Engl J Med       Date:  1997-01-23       Impact factor: 91.245

6.  Community acquired pneumonia: aetiology and usefulness of severity criteria on admission.

Authors:  A M Neill; I R Martin; R Weir; R Anderson; A Chereshsky; M J Epton; R Jackson; M Schousboe; C Frampton; S Hutton; S T Chambers; G I Town
Journal:  Thorax       Date:  1996-10       Impact factor: 9.139

7.  Validation of a pneumonia prognostic index using the MedisGroups Comparative Hospital Database.

Authors:  M J Fine; D E Singer; B H Hanusa; J R Lave; W N Kapoor
Journal:  Am J Med       Date:  1993-02       Impact factor: 4.965

8.  Predicting death in patients hospitalized for community-acquired pneumonia.

Authors:  B M Farr; A J Sloman; M J Fisch
Journal:  Ann Intern Med       Date:  1991-09-15       Impact factor: 25.391

9.  Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis.

Authors:  M J Fine; M A Smith; C A Carson; S S Mutha; S S Sankey; L A Weissfeld; W N Kapoor
Journal:  JAMA       Date:  1996-01-10       Impact factor: 56.272

10.  Community-acquired pneumonia in older patients.

Authors:  J P Janssens; L Gauthey; F Herrmann; L Tkatch; J P Michel
Journal:  J Am Geriatr Soc       Date:  1996-05       Impact factor: 5.562

View more
  758 in total

1.  Characteristics associated with clinician diagnosis of aspiration pneumonia: a descriptive study of afflicted patients and their outcomes.

Authors:  Michael J Lanspa; Paula Peyrani; Timothy Wiemken; Emily L Wilson; Julio A Ramirez; Nathan C Dean
Journal:  J Hosp Med       Date:  2014-11-01       Impact factor: 2.960

2.  Severity assessment for lower respiratory tract infections: potential use and validity of the CRB-65 in primary care.

Authors:  Nick A Francis; Jochen W Cals; Christopher C Butler; Kerenza Hood; Theo Verheij; Paul Little; Herman Goossens; Samuel Coenen
Journal:  Prim Care Respir J       Date:  2012-03

3.  Lower respiratory tract infection in the community: prognosis predictably difficult to predict.

Authors:  Paul A Marsden; Mark Woodhead
Journal:  Prim Care Respir J       Date:  2012-03

Review 4.  Community acquired pneumonia: assessment and treatment.

Authors:  Caroline M Patterson; Michael R Loebinger
Journal:  Clin Med (Lond)       Date:  2012-06       Impact factor: 2.659

Review 5.  Towards a sensible comprehension of severe community-acquired pneumonia.

Authors:  Santiago Ewig; Mark Woodhead; Antoni Torres
Journal:  Intensive Care Med       Date:  2010-11-16       Impact factor: 17.440

6.  CURB-65 pneumonia severity assessment adapted for electronic decision support.

Authors:  Barbara E Jones; Jason Jones; Thomas Bewick; Wei Shen Lim; Dominik Aronsky; Samuel M Brown; Wim G Boersma; Menno M van der Eerden; Nathan C Dean
Journal:  Chest       Date:  2010-12-16       Impact factor: 9.410

Review 7.  Validity of British Thoracic Society guidance (the CRB-65 rule) for predicting the severity of pneumonia in general practice: systematic review and meta-analysis.

Authors:  Maggie McNally; James Curtain; Kirsty K O'Brien; Borislav D Dimitrov; Tom Fahey
Journal:  Br J Gen Pract       Date:  2010-10       Impact factor: 5.386

8.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

9. 

Authors:  María José Monedero Mira; Manuel Batalla Sales; Concepción García Domingo; María José Monedero Mira; Belén Persiva Saura; Gloria Rabanaque Mallen; Lledó Tárrega Porcar
Journal:  FMC       Date:  2016-04-26

10.  Risk factors for pneumonia due to beta-lactam-susceptible and beta-lactam-resistant Pseudomonas aeruginosa: a case-case-control study.

Authors:  Mohammed J Al-Jaghbeer; Julie Ann Justo; William Owens; Joseph Kohn; P Brandon Bookstaver; Jennifer Hucks; Majdi N Al-Hasan
Journal:  Infection       Date:  2018-05-11       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.